Novartis buys Kate Therapeutics, eyeing $55B CGT market opportunity by 2030
COVID-19 critic Marty Makary is Trump’s likely pick for FDA top post
Bayer expands indications for Nubeqa with new drug application
Versant startup sets out to make a new type of obesity drug
*please scroll down for all the latest news*
